Papers Used to Populate the Database
| Paper Number (order found) | PubMed ID | Author Names | Title |
|---|---|---|---|
| 1. | 15930740 | Kiga, et al. | Expression Patterns of Plasma Proteins in Spontaneously Diabetic Rats after Oral Administration of a Kampo Medicine, Hachimi-jio-gan, Using SELDI proteinChip Platform. |
| 2. | 16581821 | Freeman, et al. | APO-AII is an elevated biomarker of chronic non-human primate ethanol self-administration. |
| 3. | 16423906 | Pang, et al. | Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome. |
| 4. | 15695329 | Le, et al. | Identification of Serum Amyloid A as a Biomarker to Distinguish Prostate Cancer Patients with Bone Lesions. |
| 5. | 16574760 | Song, et al. | Quantification of Fragments of Human Serum Inter-?-Trypsin Inhibitor Heavy Chain 4 by a Surface-Enhanced Laser Desorption/Ionization-Based Immunoassay. |
| 6. | 16644871 | Horten, et al. | The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome. |
| 7. | 16762995 | de Font, et al. | Identification of Apolipoprotein A-II in Cerebrospinal Fluid of Pediatric Brain Tumor Patients by Protein Expression Profiling. |
| 8. | 16570345 | Engwegen, et al. | Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. |
| 9. | 15269156 | Soltys, et al. | The Use of Plasma Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Proteomic Patterns for Detection of Head and Neck Squamous Cell Cancers. |
| 10. | 16755300 | Ward, et al. | Identification of serum biomarkers for colon cancer by proteomic analysis. |
| 11. | 16510150 | Clifton, et al. | Identification of members of the annexin family in the detergent-insoluble fraction of rat Morris hepatoma plasma membranes. |
| 12. | 16388609 | Ponomarenko, et al. | Induction of a Protein-Targeted Catalytic Response in Autoimmune Prone Mice: Antibody-Mediated Cleavage of HIV-1 Glycoprotein GP120. |
| 13. | 16454515 | Park, et al. | Rapid Optimization of Antibotulinum Toxin Antibody Fragment Production by an Integral Approach Utilizing RC-SELDI Mass Spectrometry and Statistical Design. |
| 14. | 16549361 | Novikova, et al. | Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. |
| 15. | 16624266 | Zhu, et al. | Analysis of ligand binding by bioaffinity mass spectrometry. |
| 16. | 16941571 | Wang, et al. | Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma. |
| 17. | 16622832 | Hou, et al. | Proteomic changes in hearts of kyphoscoliosis (ky) mutant mice in the absence of structural pathology: Implication for the analysis of early human heart disease. |
| 18. | 16828742 | Liang, et al. | Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. |
| 19. | 16797897 | Cho, et al. | Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS. |
| 20. | 16039405 | Gericke, et al. | Influence of hormone replacement therapy on proteomic pattern in serum of postmenopausal women. |
| 21. | 16492991 | Shah, et al. | Serum Proteomic Patterns Associated With Sleep-Disordered Breathing in Children. |
| 22. | 15709174 | Malik, et al. | Serum Levels of an Isoform of Apolipoprotein A-II as a Potential Marker for Prostate Cancer. |
| 23. | 16567365 | Tan, et al. | Finding regions of significance in SELDI measurements for identifying protein biomarkers. |
| 24. | 15107802 | Tolson, et al. | Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. |
| 25. | 16618908 | Gourin, et al. | Serum Protein Profile Analysis in Patients With Head and Neck Squamous Cell Carcinoma. |
| 26. | 16621968 | Tomosugi, et al. | Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. |
| 27. | 16736004 | Wibom, et al. | Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment. |
| 28. | 16154129 | Ruetschi, et al. | Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. |
| 29. | 16893915 | Schweigert, et al. | Peptide and protein profiles in serum and follicular fluid of women undergoing IVF. |
| 30. | 16708360 | Ho, et al. | Surface-Enhanced Laser Desorption/Ionization Timeof-Flight Mass Spectrometry Serum Protein Profiling to Identify Nasopharyngeal Carcinoma. |
| 31. | 16598775 | Chu, et al. | Differential Expression of Proteins in Kidney, Eye, Aorta, and Serum of Diabetic and Non-Diabetic Rats |
| 32. | 16586433 | Lee, et al. | Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. |
| 33. | 16552784 | Millis, et al. | Diagnosis of congenital disorders of glycosylation type-I using protein chip technology. |
| 34. | 16493708 | Abdul-Salam, et al. | Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension. |
| 35. | 16237736 | Kozak, et al. | Characterization of serum biomarkers for detection of early stage ovarian cancer. |
| 36. | 16052624 | Rai, et al. | Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: Multi-institution correlation of spectra and identification of biomarkers. |
| 37. | 15956344 | Hardiman, et al. | Endocrinomic profile of neurointermediate lobe pituitary prohormone processing in PC1/3- and PC2-Null mice using SELDI-TOF mass spectrometry. |
| 38. | 16624532 | Mei, et al. | Protein expression profiling of postmortem brain in schizophrenia. |
| 39. | 16596706 | Josic, et al. | Proteomic characterization of inter-alpha inhibitor proteins from human plasma. |
| 40. | 15690480 | Paradis, et al. | Identification of a New Marker of Hepatocellular Carcinoma by Serum Protein Profiling of Patients With Chronic Liver Diseases. |
| 41. | 15274116 | Sanchez, et al. | Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. |
| 42. | 15771624 | Woong-Shick, et al. | Identification of hemoglobin-? and -? subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer. |
| 43. | 16372118 | Pan, et al. | Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer. |
| 44. | 15922509 | Combaret, et al. | Protein chip array profiling analysis of sera from neuroblastoma patients. |
| 45. | 16388400 | Zhai, et al. | Proteomic profiling in the sera of workers occupationally exposed to arsenic and lead: identification of potential biomarkers. |
| 46. | 15274118 | Allard, et al. | ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. |
| 47. | 16286641 | Vermeulen, et al. | Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. |
| 48. | 16335971 | Ruetschi, et al. | Proteomic Analysis Using Protein Chips to Detect Biomarkers in Cervical and Amniotic Fluid in Women with Intra-Amniotic Inflammation. |
| 49. | 16944938 | Miguet, et al. | Discovery and Identification of Potential Biomarkers in a Prospective Study of Chronic Lymphoid Malignancies Using SELDI-TOF-MS. |
| 50. | 16837576 | Pisitkun, et al. | Discovery of Urinary Biomarkers |
| 51. | 16820428 | Du, et al. | Improved peak detection in mass spectrum by incorporating continuous wavelet transform-based pattern matching. |
| 52. | 16941699 | Scarlett, et al. | Proteomic Profiling of Cholangiocarcinoma: Diagnostic Potential of SELDI-TOF MS in Malignant Bile Duct Stricture. |
| 53. | 16586431 | Orvisky, et al. | Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. |
| 54. | 16121334 | Moshkovskii, et al. | Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. |
| 55. | 16338134 | Escher, et al. | Identification of HNP3 as a tumour marker in CD4+ and CD4? lymphocytes of patients with cutaneous T-cell lymphoma |
| 56. | 16403569 | Zhang, et al. | Biomarker discovery for ovarian cancer using SELDI-TOF-MS. |
| 57. | 16029516 | Yang, et al. | Application of serum SELDI proteomic patterns in diagnosis of lung cancer. |
| 58. | 16212425 | Lehmann, et al. | Detection and Identification of Protein Interactions of S100 Proteins by ProteinChip Technology |
| 59. | 16944932 | Zhou, et al. | Identification of the SELDI ProteinChip Human Serum Retentate by Microcapillary Liquid Chromatography-Tandem Mass Spectrometry. |
| 60. | 16459166 | Baker, et al. | The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma. |
| 61. | 16518871 | Paweletz, et al. | Surface enhanced laser desorption ionization spectrometry reveals biomarkers for drug treatment but not dose. |
| 62. | 15816004 | Guo, et al. | A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: Calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma. |
| 63. | 16803533 | Zhu, et al. | Serum proteomic features for detection of endometrial cancer. |
| 64. | 16433902 | Rossi, et al. | Detection of human MCP-4/CCL13 isoforms by SELDI immunoaffinity capture. |
| 65. | 16212435 | Melle, et al. | Characterization of Pepsinogen C as a Potential Biomarker for Gastric Cancer Using a Histo-Proteomic Approach |
| 66. | 16602693 | Suriano, et al. | Pilot Study Using SELDI-TOF-MS Based Proteomic Profile for the Identification of Diagnostic Biomarkers of Thyroid Proliferative Diseases. |
| 67. | 16908995 | Maddalena, et al. | Cerebrospinal Fluid Profile of Amyloid-? Peptides in Patients with Alzheimer?s Disease Determined by Protein Biochip Technology. |
| 68. | 17227133 | Buhimschi, et al. | Proteomic Profiling of the Amniotic Fluid to Detect Inflammation, Infection, and Neonatal Sepsis. |
| 69. | 17303688 | Timms, et al. | Preanalytic Influence of Sample Handling on SELDI-TOF Serum Protein Profiles. |
| 70. | 17046860 | Mosley, et al. | Urinary proteomic profiles distinguish between active and inactive lupus nephritis. |
| 71. | 17035609 | Jahnukainen, et al. | Proteomic Analysis of Urine in Kidney Transplant Patients with BK Virus Nephropathy. |
| 72. | 16984900 | Raju, et al. | Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. |
| 73. | 17237725 | Madan, et al. | A Potential Biomarker in the Cord Blood of Preterm Infants Who Develop Retinopathy of Prematurity. |
| 74. | 17171788 | Göbel, et al. | New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples. |
| 75. | 17178879 | Nakagawa, et al. | Proteomic Profiling of Primary Breast Cancer Predicts Axillary Lymph Node Metastasis. |
| 76. | 17054064 | Fenollar, et al. | A Serum Protein Signature with High Diagnostic Value in Bacterial Endocarditis: Results from a Study Based on Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. |
| 77. | 17318195 | Engwegen, et al. | Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations. |
| 78. | 17060939 | Ward, et al. | Preclinical and post-treatment changes in the HCC-associated serum proteome. |
| 79. | 17137555 | Akashi, et al. | Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancer. |
| 80. | 17010683 | van Breemen, et al. | Limitations in quantitation of the biomarker CCL18 in Gaucher disease blood samples by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. |
| 81. | 17321007 | Simonsen, et al. | Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer?s disease. |
| 82. | 17258689 | Meuwis, et al. | Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. |
| 83. | 17269691 | Szalowska, et al. | Fractional Factorial Design for Optimization of the SELDI Protocol for Human Adipose Tissue Culture Media. |
| 84. | 17459967 | Park, et al. | Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: Application to Mass Spec data. |
| 85. | 17427009 | Tilz, et al. | Insights into molecular medicine: Development of new diagnostic and prognostic parameters. |
| 86. | 17393466 | Kanmura, et al. | Early Diagnostic Potential for Hepatocellular Carcinoma Using the SELDI ProteinChip System. |
| 87. | 17390293 | Carlson, et al. | Biomarker clustering to address correlations in proteomic data |
| 88. | 17335062 | Wierling, et al. | High throughput screening of packed bed chromatography coupled with SELDI-TOF MS analysis: Monoclonal antibodies vs. host cell protein. |
| 89. | 17309100 | Hegedus, et al. | Screening the human serum proteome for genotype?phenotype associations: An analysis of the IL6 ?174G > C polymorphism. |
| 90. | 17115277 | Pugia, et al. | Immunological evaluation of urinary trypsin inhibitors in blood and urine: Role of N- & O-linked glycoproteins. |
| 91. | 17096316 | Purohit, et al. | Assessing the utility of SELDI-TOF and model averaging for serum proteomic biomarker discovery. |
| 92. | 17078017 | Khwaja, et al. | Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers. |
| 93. | 17072908 | Peronnet, et al. | SELDI-TOF MS analysis of the Cardiac Troponin I forms present in plasma from patients with myocardial infarction. |
| 94. | 16991122 | Munro, et al. | Urinary biomarker profiling in transitional cell carcinoma. |
| 95. | 17453148 | Zhang, et al. | Discovery of serum biomarkers in astrocytoma by SELDI?TOF MS and proteinchip technology. |
| 96. | 17052262 | Su, et al. | Diagnosis of gastric cancer using decision tree classification of mass spectral data. |
| 97. | 17442053 | Glanzer, et al. | Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation. |
| 98. | 17331118 | O?Riordan, et al. | Characterization of Urinary Peptide Biomarkers of Acute Rejection in Renal Allografts. |
| 99. | 17401465 | Escher, et al. | Posttranslational Modifications of Transthyretin Are Serum Markers in Patients with Mycosis Fungoides. |
| 100. | 17224053 | Roelofsen, et al. | Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry. |
| 101. | 17163994 | Sundsten, et al. | The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes. |
| 102. | 17081046 | Shi, et al. | Declining Plasma Fibrinogen Alpha Fragment Identifies HER2-Positive Breast Cancer Patients and Reverts to Normal Levels after Surgery. |
| 103. | 17203974 | Melle, et al. | Identification of Specific Protein Markers in Microdissected Hepatocellular Carcinoma. |
| 104. | 17310122 | Simonsen, et al. | Amyloid ? 1?40 Quantification in CSF: Comparison between Chromatographic and Immunochemical Methods. |
| 105. | 17306673 | Buhimschi, et al. | The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. |
| 106. | 17107685 | Favre-Kontula, et al. | Quantitative detection of therapeutic proteins and their metabolites in serum using antibody-coupled ProteinChip® Arrays and SELDI-TOF-MS. |
| 107. | 17097359 | Villar-Garea, et al. | Biomarker discovery from body fluids using mass spectrometry. |
| 108. | 17070117 | Schipper, et al. | SELDI-TOF-MS of saliva: Methodology and pre-treatment effects. |
| 109. | 17446058 | Bons, et al. | Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum. |
| 110. | 17139365 | Svensson, et al. | SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occuring before age 40 |
| 111. | 17258067 | Imanguli, et al. | Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation. |
| 112. | 17410539 | Skytt, et al. | SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer. |
| 113. | 12923774 | Carrette, et al. | A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer?s disease. |
| 114. | 16481598 | Pasinetti, et al. | Identification of potential CSF biomarkers in ALS. |
| 115. | 17090210 | Huang, et al. | Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset Psychosis. |
| 116. | 16313519 | Ranganathan, et al. | Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. |
| 117. | 11113131 | Park et al | Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver |
| 118. | 12973732 | Howard et al | Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis. |
| 119. | 12606051 | Kiernan et al | Detection of novel truncated forms of human serum amyloid A protein in human plasma. |
| 120. | 16673437 | Li, et al. | Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma. |